Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during …

S Muto, T Matsubara, T Inoue, H Kitamura… - International Journal of …, 2023 - Springer
The prevalence of CKD may be higher in patients with cancer than in those without due to
the addition of cancer-specific risk factors to those already present for CKD. In this review …

Assessment of Glomerular Filtration Rate in Patients with Cancer: A Statement from the American Society of Onco-Nephrology

A Kitchlu, VTCE Silva, S Anand, J Kala… - Clinical Journal of the …, 2024 - journals.lww.com
Accurate assessment of glomerular filtration rate (GFR) is crucial to guiding drug eligibility,
dosing of systemic therapy, and minimizing the risks of both undertreatment and toxicity in …

Pharmacokinetic and dose‐finding study of osimertinib in patients with impaired renal function and low body weight

Y Fujiwara, R Makihara, T Hase, N Hashimoto… - Cancer …, 2023 - Wiley Online Library
The safety of osimertinib is limited in patients with severe or moderate renal impairment, or
low body weight. This study aimed to investigate the safety, pharmacokinetics (PK) and …

Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022

M Yanagita, S Muto, H Nishiyama, Y Ando… - Clinical and …, 2024 - Springer
Background Burn patients often face a high risk of acute kidney injury (AKI) after severe burn
injuries, meanwhile epigallocatechin-3-gallate (EGCG) has been proven to be effective in …

Validity of new methods to evaluate renal function in cancer patients treated with cisplatin

Y Funakoshi, Y Fujiwara, N Kiyota, T Mukohara… - Cancer Chemotherapy …, 2016 - Springer
Abstract Purpose Creatinine clearance (Ccr) is used as a marker of renal function in cancer
chemotherapy, but it is not correlated with glomerular filtration rate (GFR) after high-dose …

Time course of calcium concentrations and risk factors for hypocalcemia in patients receiving denosumab for the treatment of bone metastases from cancer

H Ikesue, T Tsuji, K Hata, H Watanabe… - Annals of …, 2014 - journals.sagepub.com
Background: Severe hypocalcemia sometimes develops during denosumab treatment for
bone metastases from cancer and is, therefore, an important issue. However, limited …

Adjustment of creatinine clearance for carboplatin dosing in Calvert's formula and clinical efficacy for lung cancer

T Hatta, T Hase, T Hara, T Kimura, E Kojima… - Cancer …, 2023 - Wiley Online Library
Abstract Background The Cockcroft–Gault formula is commonly used as a substitute for
glomerular filtration rate (GFR) in Calvert's formula for carboplatin dosing, where adjusting …

Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS study

M Shiroyama, S Fukuoka, T Masuishi, A Takashima… - Scientific Reports, 2023 - nature.com
Renal impairment may be associated with an increased risk of hematologic events (AEs) in
patients undergoing treatment with trifluridine/tipiracil (FTD/TPI). This study aimed to …

Reliability of estimated glomerular filtration rate in patients treated with platinum containing therapy

J Lauritsen, MG Gundgaard… - … journal of cancer, 2014 - Wiley Online Library
Estimates of glomerular filtration rate (eGFR) are widely used when administering
nephrotoxic chemotherapy. No studies performed in oncology patients have shown whether …

Comparison of methods to estimate glomerular filtration rate in paediatric oncology patients

CC Llanos‐Paez, C Staatz, R Lawson… - Journal of Paediatrics …, 2018 - Wiley Online Library
Aims Glomerular filtration rate (GFR) is estimated daily in paediatric oncology patients;
however, few equations, particularly ones that do not include serum creatinine, have been …